Three prognostic factors influence clinical outcomes of primary testicular lymphoma

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

(2011) W. M. Tai et al.   ANNALS OF HEMATOLOGY

A clinical analysis of primary testicular diffuse large B-cell lymphoma in China

(2011) Bing Cao et al.   Hematology

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

(2011) Umberto Vitolo et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience

(2010) Ali Mazloom et al.   LEUKEMIA & LYMPHOMA

Primary Testicular Diffuse Large B-Cell Lymphoma: A Population-Based Study on the Incidence, Natural History, and Survival Comparison With Primary Nodal Counterpart Before and After the Introduction of Rituximab

(2009) Jacob D. Gundrum et al.   JOURNAL OF CLINICAL ONCOLOGY

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

(2008) Michael Pfreundschuh et al.   LANCET ONCOLOGY

Primary testicular lymphoma

(2007) Umberto Vitolo et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY